Clinical Trial: ALLIANCE A071701

A071701 will be closed to accrual  effective September 2, 2025, at 4:30 pm ET.

A071701 will be temporarily closed to accrual to patient registration (Step 1) to the abemaciclib & paxalisib, effective September 2, 2025, at 4:30 pm ET.

A071701 will be temporarily closed to accrual to pre-registration (Step 0), effective August 5, 2025, at 4:30 pm ET.

A071701-MRTX849 (adagrasib) (KRAS G12C) Cohort is closed to accrual of new patients (Step 1), effective Friday, April 4, 2025.

 A071701-Eentrectinib (NTRK/ROS1) Cohort is closed to accrual of new patients (Step 1) effective January 9, 2024.